1-3 of 3
Faizan Khan
Close
Sort by
Journal Articles

Clinical Benefits, Harms, and Cost-Effectiveness of Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Decision Analytic Modelling Study

Faizan Khan, Doug Coyle, Kednapa Thavorn, Sasha van Katwyk, Tobias Tritschler, Brian Hutton, Gregoire Le Gal, Marc A. Rodger, Dean Fergusson
Journal: Blood
Blood (2022) 140 (Supplement 1): 7858–7859.
https://doi.org/10.1182/blood-2022-158006
Published: 2022
Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Faizan Khan, BSc, Alvi Rahman, MSc, Marc Carrier, MD MSc, Clive Kearon, MB, PhD, Jeffrey I. Weitz, MD, Sam Schulman, MD PhD FRCPC, Francis Couturaud, MD PhD, Sabine Eichinger, MD, Paul Alexander Kyrle, MD, Cecilia Becattini, MD PhD, Giancarlo Agnelli, MD, Timothy Brighton, MD, Anthonie WA. Lensing, MD PhD, Martin H. Prins, MD PhD, Elham Sabri, MSc, Brian Hutton, PhD, Laurent Pinede, MD PhD, Mary Cushman, MD MSc, Gualtiero Palareti, MD, George Wells, PhD, Paolo Prandoni, MD PhD, Harry R. Büller, MD PhD, Marc A. Rodger, MD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 2527.
https://doi.org/10.1182/blood-2018-99-113589
Published: 2018
Journal Articles

A Decision Model to Estimate Risk Thresholds for Guiding Duration of Anticaogulation in Unprovoked Venous Thromboembolism

Faizan Khan, BSc, Kednapa Thavorn, MPharm, PhD, Doug Coyle, MA, MSc, PhD, Marc A Rodger, MD MSc, FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 4641.
https://doi.org/10.1182/blood.V130.Suppl_1.4641.4641
Published: 2017